Cite
HARVARD Citation
Rosner, S. et al. (2017). Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone. Journal for immunotherapy of cancer. 5 (1), p. . [Online].